Immunodeficiency: A Protective Factor for COVID-19?

Coronavirus disease 2019 (COVID-19) is an infection that involves the respiratory tract and is attributed to severe acute respiratory syndrome coronavirus 2. While most people develop mild or uncomplicated illness, approximately 15% develop a severe disease that requires oxygen support, and 5% devel...

Descripción completa

Detalles Bibliográficos
Autores principales: AlShanableh, Zain, Haidous, Mohammad, Wong, Krista M, Al-Saed, Mohamad, Altaqi, Basel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996821/
https://www.ncbi.nlm.nih.gov/pubmed/35464498
http://dx.doi.org/10.7759/cureus.23094
_version_ 1784684560160653312
author AlShanableh, Zain
Haidous, Mohammad
Wong, Krista M
Al-Saed, Mohamad
Altaqi, Basel
author_facet AlShanableh, Zain
Haidous, Mohammad
Wong, Krista M
Al-Saed, Mohamad
Altaqi, Basel
author_sort AlShanableh, Zain
collection PubMed
description Coronavirus disease 2019 (COVID-19) is an infection that involves the respiratory tract and is attributed to severe acute respiratory syndrome coronavirus 2. While most people develop mild or uncomplicated illness, approximately 15% develop a severe disease that requires oxygen support, and 5% develop a critical disease. While immunodeficiency is reported as a risk factor for COVID-19, we present a patient with idiopathic CD4+ lymphocytopenia who developed severe COVID-19 with an unexpected clinical course and complete recovery.
format Online
Article
Text
id pubmed-8996821
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-89968212022-04-23 Immunodeficiency: A Protective Factor for COVID-19? AlShanableh, Zain Haidous, Mohammad Wong, Krista M Al-Saed, Mohamad Altaqi, Basel Cureus Internal Medicine Coronavirus disease 2019 (COVID-19) is an infection that involves the respiratory tract and is attributed to severe acute respiratory syndrome coronavirus 2. While most people develop mild or uncomplicated illness, approximately 15% develop a severe disease that requires oxygen support, and 5% develop a critical disease. While immunodeficiency is reported as a risk factor for COVID-19, we present a patient with idiopathic CD4+ lymphocytopenia who developed severe COVID-19 with an unexpected clinical course and complete recovery. Cureus 2022-03-12 /pmc/articles/PMC8996821/ /pubmed/35464498 http://dx.doi.org/10.7759/cureus.23094 Text en Copyright © 2022, AlShanableh et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
AlShanableh, Zain
Haidous, Mohammad
Wong, Krista M
Al-Saed, Mohamad
Altaqi, Basel
Immunodeficiency: A Protective Factor for COVID-19?
title Immunodeficiency: A Protective Factor for COVID-19?
title_full Immunodeficiency: A Protective Factor for COVID-19?
title_fullStr Immunodeficiency: A Protective Factor for COVID-19?
title_full_unstemmed Immunodeficiency: A Protective Factor for COVID-19?
title_short Immunodeficiency: A Protective Factor for COVID-19?
title_sort immunodeficiency: a protective factor for covid-19?
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996821/
https://www.ncbi.nlm.nih.gov/pubmed/35464498
http://dx.doi.org/10.7759/cureus.23094
work_keys_str_mv AT alshanablehzain immunodeficiencyaprotectivefactorforcovid19
AT haidousmohammad immunodeficiencyaprotectivefactorforcovid19
AT wongkristam immunodeficiencyaprotectivefactorforcovid19
AT alsaedmohamad immunodeficiencyaprotectivefactorforcovid19
AT altaqibasel immunodeficiencyaprotectivefactorforcovid19

Ejemplares similares